Prosight Management

Prosight Management as of Dec. 31, 2017

Portfolio Holdings for Prosight Management

Prosight Management holds 29 positions in its portfolio as reported in the December 2017 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Allergan 11.8 $16M 98k 163.58
Macrogenics (MGNX) 8.5 $12M 608k 19.00
Cidara Therapeutics Inc Common Stock Usd 0.0001 8.2 $11M 1.6M 6.80
Eiger Biopharmaceuticals 7.0 $9.5M 679k 13.95
Sabra Health Care REIT (SBRA) 5.5 $7.5M 402k 18.77
Centene Corporation (CNC) 5.3 $7.2M 71k 100.87
Chimerix (CMRX) 5.0 $6.8M 1.5M 4.63
Achaogen 4.5 $6.1M 571k 10.74
Uniqure Nv (QURE) 4.1 $5.6M 285k 19.59
Almost Family 3.7 $5.0M 91k 55.35
Reata Pharmaceuticals Inc Cl A 3.6 $4.9M 173k 28.32
Quotient 3.4 $4.6M 933k 4.95
Ignyta 3.4 $4.6M 171k 26.70
Iovance Biotherapeutics (IOVA) 3.0 $4.1M 507k 8.00
Endologix 2.6 $3.5M 656k 5.35
Radius Health 2.6 $3.5M 110k 31.77
Paratek Pharmaceuticals 2.4 $3.2M 179k 17.90
AVEO Pharmaceuticals 2.2 $3.0M 1.1M 2.79
Nabriva Therapeutics 2.2 $2.9M 491k 5.98
Clovis Oncology 2.0 $2.7M 40k 68.00
Bellicum Pharma 1.9 $2.5M 301k 8.41
Ultragenyx Pharmaceutical (RARE) 1.5 $2.1M 45k 46.39
Dex (DXCM) 1.3 $1.8M 31k 57.38
On Assignment 1.2 $1.7M 26k 64.28
Lipocine 0.9 $1.3M 373k 3.44
Conformis 0.7 $952k 400k 2.38
Noveliontherapeuti.. 0.7 $925k 297k 3.12
Acadia Healthcare (ACHC) 0.7 $878k 27k 32.62
Adamas Pharmaceuticals 0.3 $407k 12k 33.92